Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy

NCT06888661 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinal Muscular Atrophy (SMA)

Interventions

BIOLOGICAL: EXG001-307 injection

Sponsor

Guangzhou Jiayin Biotech Ltd